Oscar Health OSCR Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $4.83B+114% | $2.8B+80.8% | $2.17B+76.4% | $2.62B+14.5% | $2.26B+0.3% | ||
| $1.99B+165% | $1.22B+94.8% | $887.59M+76.2% | $938.1M+158% | $751.49M+22.0% | ||
| $24.11M+1.5% | $29.97M+25.2% | $23.89M-7.3% | $24.36M+5.3% | $23.75M+6.7% | ||
| —— | —— | —— | —— | —— | ||
| $25.82M+12.2% | $24.33M+14.1% | $28.59M+38.4% | $30.46M+96.4% | $23.02M+156% | ||
| $1.99B+165% | $1.22B+94.8% | $887.59M+76.2% | $938.1M+158% | $751.49M— | ||
| $23.1M+0.4% | $20.2M+2.0% | $23.4M+13.0% | $21.8M+40.6% | $23M— | ||
| $7.78B+106% | $4.61B+62.1% | $3.76B+58.9% | $4.31B+28.4% | $3.77B+7.7% | ||
| $94.19M+30.8% | $88.35M+32.3% | $83.42M+25.2% | $77.67M+21.4% | $72M+17.2% | ||
| -$3.79M-70.5% | $2.45M+205% | -$2.45M— | -$2.39M— | -$2.22M— | ||
| $122.74M+31.2% | $119.72M+45.3% | $120.65M+43.0% | $116.27M+33.2% | $93.58M+7.3% | ||
| $3.91M— | $2.41M— | $2.41M— | —— | —— | ||
| $3.26B— | $2.69B— | $2.64B— | —— | —— | ||
| $1.17B-35.4% | $1.39B-23.7% | $1.65B-14.8% | $1.74B+18.5% | $1.81B+146% | ||
| $142.49M-24.0% | $99.75M-65.8% | $159.39M-41.7% | $192.7M-20.1% | $187.55M-22.8% | ||
| $9.29B+59.0% | $6.33B+30.7% | $5.75B+28.2% | $6.38B+27.5% | $5.84B+32.2% | ||
| $505.94M-20.2% | $507.33M+17.3% | $556.73M+40.8% | $583.87M+68.0% | $634.01M+109% | ||
| —— | —— | —— | —— | —— | ||
| $172M+143% | $166.2M+123% | $77.12M+16.6% | $69.49M+15.9% | $70.9M+8.2% | ||
| $5.11M-78.4% | $3.58M-91.3% | $7.28M-85.8% | $13.38M-77.7% | $23.64M-61.8% | ||
| $7.14B+72.1% | $4.86B+40.4% | $3.98B+34.6% | $4.87B+38.9% | $4.15B+37.4% | ||
| $430.88M+43.7% | $430.1M+43.6% | $686.29M+129% | $299.94M+0.3% | $299.75M+0.3% | ||
| —— | —— | —— | —— | —— | ||
| $51.37M-13.4% | $51.99M-15.2% | $55.77M-12.2% | $57.27M-11.4% | $59.33M-10.3% | ||
| $1.73B+18.3% | $1.46B+7.3% | $1.56B+15.3% | $1.55B+23.9% | $1.47B+17.4% | ||
| $7.62B+69.1% | $5.34B+39.8% | $4.72B+42.2% | $5.22B+35.1% | $4.51B+33.2% | ||
| $4.28B+9.6% | $4.26B+10.0% | $3.95B+3.0% | $3.95B+4.4% | $3.9B+4.4% | ||
| -$2.62B-1.5% | -$3.29B-15.5% | -$2.94B-9.0% | -$2.8B-6.1% | -$2.58B+4.6% | ||
| $5M-47.9% | $18.03M+1,087% | $16.39M-37.1% | $13.72M+623% | $9.6M+470% | ||
| $2.92M0.0% | $2.92M0.0% | $2.92M0.0% | $2.92M0.0% | $2.92M0.0% | ||
| $3.11M+1.3% | $3.09M+8.7% | $2.91M+12.9% | $2.94M+24.3% | $3.07M+35.8% | ||
| $1.66B+24.8% | $977.65M-3.5% | $1.02B-11.9% | $1.16B+1.8% | $1.33B+29.2% | ||
| $9.29B+59.0% | $6.33B+30.7% | $5.75B+28.2% | $6.38B+27.5% | $5.84B+32.2% | ||
| $1.99B+166% | $1.21B+94.6% | $885.2M+76.1% | $936.16M+157% | $750.09M— | ||
| $1.99B+166% | $1.21B+94.6% | $885.2M+76.1% | $936.16M+157% | $750.09M— | ||
| 3— | 5-16.7% | 83+1,086% | 0-100% | 0— | ||
| $29.98M— | $40.78M-14.6% | $344.42M+576% | $0-100% | $0— | ||
| $1.04B+62.2% | $347.68M-60.4% | $236.76M-57.3% | $759.6M-39.8% | $641.56M— | ||
| $1.04B+62.2% | $347.68M-60.4% | $236.76M-57.3% | $759.6M-39.8% | $641.56M— | ||
| $29.98M— | $40.78M-14.6% | $344.42M+576% | $0-100% | $0— | ||
| $1.04B+62.2% | $347.68M-60.4% | $236.76M-57.3% | $759.6M-39.8% | $641.56M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $3.26B+24.2% | $2.69B+10.2% | $2.64B+8.2% | $2.78B+52.0% | $2.62B— | ||
| $1.99B+165% | $1.22B+94.8% | $887.59M+76.2% | $938.1M+158% | $751.49M+22.0% | ||
| $25.82M+12.2% | $24.33M+14.1% | $28.59M+38.4% | $30.46M+96.4% | $23.02M+156% | ||
| —— | —— | —— | —— | —— | ||
| $3.91M— | $2.41M— | $2.41M— | —— | —— | ||
| $1.17B-35.3% | $1.37B-24.4% | $1.64B-14.3% | $1.73B+17.6% | $1.81B— | ||
| $122.74M+31.2% | $119.72M+45.3% | $120.65M+43.0% | $116.27M+33.2% | $93.58M+7.3% | ||
| $3.91M— | $2.41M— | $2.41M— | —— | —— | ||
| $3.91M+62.3% | $2.41M0.0% | $2.41M-99.9% | $2.41M-99.9% | $2.41M— | ||
| $1.27B-32.4% | $1.47B-19.0% | $1.75B-9.4% | $1.85B+25.9% | $1.87B+154% | ||
| $3.26B— | $2.69B— | $2.64B— | —— | —— | ||
| $122.74M+31.2% | $119.72M+45.3% | $120.65M+43.0% | $116.27M+33.2% | $93.58M+7.3% | ||
| $28.63M-7.7% | $32.95M+6.7% | $27.92M-7.2% | $31.09M+4.1% | $31.01M+4.0% | ||
| $28.63M-7.7% | $32.95M+6.7% | $27.92M-7.2% | $31.09M+4.1% | $31.01M+4.0% | ||
| —— | —— | —— | —— | —— | ||
| $122.74M+31.2% | $119.72M+45.3% | $120.65M+43.0% | $116.27M+33.2% | $93.58M+7.3% | ||
| $505.94M-20.2% | $507.33M+17.3% | $556.73M+40.8% | $583.87M+68.0% | $634.01M+109% | ||
| $1.73B+18.3% | $1.46B+7.3% | $1.56B+15.3% | $1.55B+23.9% | $1.47B+17.4% | ||
| —— | —— | —— | —— | —— | ||
| $90.72M— | $82.84M— | $100.85M— | —— | —— | ||
| $430.88M+43.7% | $498.8M+33.5% | $686.29M+129% | $299.94M+0.3% | $299.75M+0.3% | ||
| $214K— | $120K+380% | $1.06M+1,475% | $0-100% | $0— | ||
| 270+31.1% | 107-64.5% | 107-35.2% | 243-50.4% | 206— | ||
| $2.92M0.0% | $2.92M0.0% | $2.92M0.0% | $2.92M0.0% | $2.92M0.0% | ||
| $8.48M-40.5% | $18.63M+134% | $18.35M-32.4% | $16.91M+661% | $14.25M— | ||
| $3.5M-19.1% | $615K-93.7% | $1.36M+20.2% | $2.72M-43.8% | $4.32M— | ||
| $3.25B+24.5% | $2.67B+9.3% | $2.62B+8.6% | $2.77B+51.0% | $2.61B— | ||
| —— | —— | —— | —— | —— | ||
| $3.5M-19.1% | $615K-93.7% | $1.36M+20.2% | $2.72M-43.8% | $4.32M— | ||
| $8.48M-40.5% | $18.63M+134% | $18.35M-32.4% | $16.91M+661% | $14.25M— | ||
| $3.25B+24.5% | $2.67B+9.3% | $2.62B+8.6% | $2.77B+51.0% | $2.61B— | ||
| $90.84M— | $81.97M— | $98.97M— | —— | —— | ||
| $90.72M— | $82.84M— | $100.85M— | —— | —— | ||
| $1.17B-35.3% | $1.37B-24.4% | $1.64B-14.3% | $1.73B+17.6% | $1.81B— | ||
| $1.17B-35.4% | $1.39B-23.6% | $1.65B-14.8% | $1.74B+18.5% | $1.81B— | ||
| $1.99B+166% | $1.21B+94.6% | $885.2M+76.1% | $936.16M+157% | $750.09M— | ||
| $1.99B+165% | $1.22B+94.8% | $887.59M+76.2% | $938.1M+158% | $751.49M— | ||
| $3.26B+24.2% | $2.69B+10.2% | $2.64B+8.2% | $2.78B+52.0% | $2.62B— | ||
| $214K— | $120K+380% | $1.06M+1,475% | $0-100% | $0— | ||
| $1.04B+62.2% | $347.68M-60.4% | $236.76M-57.3% | $759.6M-39.8% | $641.56M— | ||
| $29.98M— | $40.78M-14.6% | $344.42M+576% | $0-100% | $0— | ||
| $3— | $5-16.7% | $83+1,086% | $0-100% | $0— | ||
| $3.28M-24.1% | $495K-95.0% | $305K-71.3% | $2.72M-38.2% | $4.32M— | ||
| $3.91M— | $2.41M— | $2.41M— | —— | —— | ||
| $3.26B— | $2.67B— | $2.62B— | —— | —— | ||
| $1.76B+18.3% | $1.47B+7.3% | $1.59B+15.2% | $1.57B+23.9% | $1.49B+17.4% | ||
| $1.69B+17.7% | $1.43B+10.1% | $1.54B+18.4% | $1.53B+28.0% | $1.43B+20.5% | ||
| $22.58M+16.1% | $19.31M+5.9% | $20.64M+10.0% | $20.54M+21.2% | $19.45M+15.2% | ||
| $1.71B+17.7% | $1.45B+10.0% | $1.56B+18.3% | $1.55B+27.9% | $1.45B+20.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $3.11M+1.3% | $3.09M+8.7% | $2.91M+12.9% | $2.94M+24.3% | $3.07M+35.8% | ||
| —— | —— | —— | —— | —— | ||
| $154.2M+202% | $140.5M+933% | $93.6M+609% | $45.7M+254% | $51.1M— | ||
| $7M0.0% | $7M+0.1% | $7M+1.3% | $7M-0.2% | $7M— | ||
| -$5.27M-0.4% | -$5.27M-21.4% | -$5.27M+13.3% | -$5.24M+37.4% | -$5.24M— | ||
| $140.75M-24.2% | $98.01M-66.1% | $157.65M-42.1% | $190.94M-21.3% | $185.79M— | ||
| $48.41M+45.1% | $26.54M-54.7% | $27.81M-53.0% | $19.55M-64.5% | $33.35M-44.2% | ||
| $4.52M-37.7% | $2.98M-57.1% | $4.03M-6.0% | $6.73M0.0% | $7.26M— | ||
| $3.97B+113% | $2.53B— | $1.68B— | $2.56B— | $1.87B— | ||
| $4.05B+107% | $2.59B— | $1.77B— | $2.65B— | $1.95B— | ||
| $77.31M-11.3% | $56.07M— | $92.58M— | $87.62M— | $87.13M— | ||
| $315K0.0% | $315K0.0% | $315K0.0% | $315K0.0% | $315K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Oscar Health's total assets?
- Oscar Health (OSCR) holds $9.3B in total assets, up 59.0% year over year.
- How much debt does Oscar Health have?
- Oscar Health carries $430.9M in total debt against $1.7B of shareholders' equity, a debt-to-equity ratio of 0.26.
- How much cash does Oscar Health have?
- Oscar Health holds $4.8B in cash and equivalents.
- Can Oscar Health cover its short-term obligations?
- Its current ratio is 1.09 — current assets exceed current liabilities.
- Where does Oscar Health's balance sheet data come from?
- Every line is extracted from Oscar Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
